During the past decade, North Mississippi Medical Center/Cancer Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 14 clinical trials were completed, i.e. on average, 175% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Mississippi Medical Center/Cancer Center" #1 sponsor was "Radiation Therapy Oncology Group" with 11 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Mississippi Medical Center/Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma" with 1 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator, "Ono Pharma USA Inc" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "North Mississippi Medical Center/Cancer Center" are "Lung Cancer" (3 trials), "Non-Small Cell Lung Cancer" (3 trials), "Prostate Cancer" (3 trials), "Breast Cancer" (2 trials) and "Head and Neck Cancer" (2 trials). Many other conditions were trialed in "North Mississippi Medical Center/Cancer Center" in a lesser frequency.

Most popular intervention types in "North Mississippi Medical Center/Cancer Center" are "Drug" (24 trials), "Radiation" (9 trials), "Biological" (7 trials), "Procedure" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (9 trials), "Carboplatin" (3 trials), "Gemcitabine" (3 trials), "quality-of-life assessment" (3 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "North Mississippi Medical Center/Cancer Center" are 27 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "North Mississippi Medical Center/Cancer Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in North Mississippi Medical Center/Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in North Mississippi Medical Center/Cancer Center, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".